HIGH-VOLUME · HOSP-HEAVY
glimepiride Side Effects
glimepiride (also sold as Amaryl) is HIGH-VOLUME in this FAERS book #165 of 524 by FAERS report count. Signature opener: HOSP-HEAVY - 35.7% mention hospitalization (13,533 reports).
Data updated 2026-05-15
- 37,936
- FAERS reports
FAERS voluntary reports, 2003 to 2025. High volume tracks exposure and reporting culture; see methodology for de-dup rules.
glimepiride: 35.7% mention hospitalization (13,533 reports). Death stamp DEATH-HEAVY; volume band HIGH-VOLUME #165 of 524 by FAERS report count.
High-report extract for glimepiride (Amaryl): 37,936 FAERS rows (2003-2025). Top named reactions: BLOOD GLUCOSE INCREASED, NAUSEA, DIARRHOEA. Outcome stamps DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED. FAERS is voluntary signal detection, not incidence.
Counts from the openFDA FAERS extract (2003–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
BLOOD GLUCOSE INCREASED leads 2,970 of 37,936 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (8,920 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (3,187 reports, 8.4%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,007 |
| COMPLETED SUICIDE | 188 |
| RENAL FAILURE | 176 |
| ACUTE KIDNEY INJURY | 166 |
| PNEUMONIA | 163 |
| DYSPNOEA | 133 |
| CARDIAC ARREST | 130 |
| DIARRHOEA | 118 |
| CHRONIC KIDNEY DISEASE | 116 |
| HYPOGLYCAEMIA | 109 |
| ANAEMIA | 102 |
| NAUSEA | 102 |
| MYOCARDIAL INFARCTION | 101 |
| TOXICITY TO VARIOUS AGENTS | 98 |
| RESPIRATORY FAILURE | 95 |
| SEPSIS | 95 |
| CARDIAC FAILURE | 89 |
| LACTIC ACIDOSIS | 87 |
| FALL | 85 |
| FATIGUE | 84 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (13,533, 35.7% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| HYPOGLYCAEMIA | 1,108 |
| ACUTE KIDNEY INJURY | 752 |
| PNEUMONIA | 725 |
| DIARRHOEA | 724 |
| NAUSEA | 720 |
| FALL | 695 |
| DYSPNOEA | 673 |
| VOMITING | 647 |
| ASTHENIA | 550 |
| BLOOD GLUCOSE INCREASED | 539 |
| FATIGUE | 512 |
| RENAL FAILURE | 503 |
| DEHYDRATION | 494 |
| LACTIC ACIDOSIS | 482 |
| ANAEMIA | 463 |
| DECREASED APPETITE | 458 |
| DIZZINESS | 425 |
| WEIGHT DECREASED | 419 |
| HYPOTENSION | 412 |
| MALAISE | 401 |
How to read glimepiride FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 37,936 voluntary reports linked to glimepiride (Amaryl), 2003-2025. Death is listed on 3,187 (8.4%). Hospitalization appears on 13,533 (35.7%). Top co-reported indication: Product Used For Unknown Indication.
CASELOAD books overweight common drugs and loud reporting cultures; HOSP-HEAVY is the page opener, not a per-patient risk.
Read with glimepiride
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 38,197 FAERS cases (Δ 261 heavier vs glimepiride); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 37,361 FAERS cases (Δ 575 lighter vs glimepiride); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 38,664 FAERS cases (Δ 728 heavier vs glimepiride); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 37,033 FAERS cases (Δ 903 lighter vs glimepiride); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 53.7 pp vs glimepiride's DEATH-HEAVY): CASELOAD · HOSP-MID.
glimepiride stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.